Incorporating of herd immunity into pharmacoeconomic evaluation of pneumococcal conjugate vaccine PNC-7

被引:1
|
作者
Claes, C
Reinert, RR
Schulenburg, JM
机构
[1] Univ Hannover, Hannover, Germany
[2] Inst Med Microbiol, Aachen, Germany
关键词
D O I
10.1016/S1098-3015(10)62761-1
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:298 / 298
页数:1
相关论文
共 50 条
  • [31] Clinical and economic impact of herd immunity associated with heptavalent pneumococcal conjugate vaccination in Canada
    Ford, MW
    Wang, ECY
    Ciuryla, V
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 357 - 357
  • [32] Essential criteria for evaluation of pneumococcal conjugate vaccine candidates
    Paradiso, Peter
    [J]. VACCINE, 2009, 27 : C15 - C18
  • [33] Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects
    Lloyd, Adam
    Patel, Nishma
    Scott, David A.
    Runge, Claus
    Claes, Christa
    Rose, Markus
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 9 (01): : 7 - 15
  • [34] Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects
    Adam Lloyd
    Nishma Patel
    David A. Scott
    Claus Runge
    Christa Claes
    Markus Rose
    [J]. The European Journal of Health Economics, 2008, 9 : 7 - 15
  • [35] Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine in Children Previously Immunized With 7-valent Pneumococcal Conjugate Vaccine
    Frenck, Robert, Jr.
    Thompson, Allison
    Yeh, Sylvia H.
    London, Arnold
    Sidhu, Mohinder S.
    Patterson, Scott
    Gruber, William C.
    Emini, Emilio A.
    Scott, Daniel A.
    Gurtman, Alejandra
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (12) : 1086 - 1091
  • [36] A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent) on Pneumococcal Meningitis
    Htar, Myint Tin Tin
    Madhava, Harish
    Balmer, Paul
    Christopoulou, Dina
    Menegas, Damianos
    Bonnet, Eric
    [J]. ADVANCES IN THERAPY, 2013, 30 (08) : 748 - 762
  • [37] A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent) on Pneumococcal Meningitis
    Myint Tin Tin Htar
    Harish Madhava
    Paul Balmer
    Dina Christopoulou
    Damianos Menegas
    Eric Bonnet
    [J]. Advances in Therapy, 2013, 30 : 748 - 762
  • [38] Incorporating Herd Immunity Effects into Cohort Models of Vaccine Cost-Effectiveness
    Bauch, Chris T.
    Anonychuk, Andrea M.
    Van Effelterre, Thierry
    Pham, Ba' Z.
    Merid, Maraki Fikre
    [J]. MEDICAL DECISION MAKING, 2009, 29 (05) : 557 - 569
  • [39] Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine
    Zielen, S
    Bühring, I
    Strnad, N
    Reichenbach, J
    Hofmann, D
    [J]. INFECTION AND IMMUNITY, 2000, 68 (03) : 1435 - 1440
  • [40] Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine
    Sobanjo-ter Meulen, Ajoke
    Vesikari, Timo
    Malacaman, Edgardo A.
    Shapiro, Steven A.
    Dallas, Michael J.
    Hoover, Patricia A.
    McFetridge, Richard
    Stek, Jon E.
    Marchese, Rocio D.
    Hartzel, Jonathan
    Watson, Wendy J.
    Musey, Luwy K.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (02) : 186 - 194